Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Free Cash Flow (2025)

Updated

Drugs Made In America Acquisition (DMAA) recorded Free Cash Flow of -$125,180 in Q4 2025.

Analysis

Drugs Made In America Acquisition (DMAA) Free Cash Flow (2025) Analysis & Trends

For FY2025, Drugs Made In America Acquisition reported Free Cash Flow of -$539,187.

  • Across earlier years, Free Cash Flow came in at -$172,265 in FY2024.
  • Quarterly Free Cash Flow has ranged from -$251,244 in Q1 2025 to -$56,108 in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$56,108 (Q3 2025), -$106,655 (Q2 2025) and -$251,244 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 BlackRock 165.40 Bn 111.76 Bn - 1.12 Bn
2 Spdr Gold Trust 133.61 Bn -424.39 Bn - -
3 Blackstone 84.03 Bn 78.95 Bn - 1.91 Bn
4 Brookfield 82.79 Bn -82.59 Bn 4.47 Bn -
5 Kkr 80.75 Bn 47.23 Bn - 3.20 Bn
6 Brookfield Asset Management 71.44 Bn 67.69 Bn - 535.00 Mn
7 Apollo Global Management 66.43 Bn 4.11 Bn 10.56 Bn 2.88 Bn
8 Wheaton Precious Metals 61.87 Bn 57.29 Bn 687.86 Mn 649.52 Mn
9 Franco Nevada 46.42 Bn 43.78 Bn 451.00 Mn 482.60 Mn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -125,180.00
Sep 30, 2025 -56,108.00
Jun 30, 2025 -106,655.00
Mar 31, 2025 -251,244.00
API Access

Drugs Made In America Acquisition Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=DMAA&period=max&api_key=YOUR_API_KEY